David W J McGirr's Net Worth

$6.62 Million

Estimate Recalculated Jul 10, 2024 04:21PM EST

Who is David W J McGirr?

David W J McGirr has an estimated net worth of $6.62 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., Relypsa Inc, INSMED Inc, Menlo Therapeutics Inc., X4 Pharmaceuticals, Inc, Roka BioScience, Inc., CUBIST PHARMACEUTICALS INC, and LIFECELL CORP.

SEC CIK

David W J McGirr's CIK is 0001219023

Past Insider Trading and Trends

2012 was David W J McGirr's most active year for acquiring shares with 9 total transactions. David W J McGirr's most active month to acquire stocks was the month of May. 2007 was David W J McGirr's most active year for disposing of shares, totalling 21 transactions. David W J McGirr's most active month to dispose stocks was the month of June. 2008 saw David W J McGirr paying a total of $530,852.04 for 110,562 shares, this is the most they've acquired in one year. In 2012 David W J McGirr cashed out on 104,875 shares for a total of $2,300,905.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.865

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3K
3K
Jun 21
Form 4
0
0
Jun 18
Form 4
0
0
Jun 21
Form 4
0
0
Jun 8
Form 4
0
0
Jun 9
Form 4
0
0
Jun 17
Form 4
0
0
Jun 19
Form 4
0
0
Jun 6
Form 3
0
0
No matching records found

Relypsa Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.98K
$32.00
-$159,328.00
0
Sep 1
Form 4
+82.45%
2.25K
4.98K
Jun 21
Form 4
-27.07%
-1.01K
$19.34
-$19,587.98
2.73K
Jun 7
Form 4
-24.59%
-1.22K
$34.67
-$42,300.33
3.74K
Scheduled
Jun 11
Form 4
+82.96%
2.25K
4.96K
Jun 4
Form 4
2.71K
2.71K
Jun 19
Form 3
0
0
No matching records found

INSMED Inc (INSM) Snapshot price: $29.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+15.35%
13.16K
98.92K
May 13
Form 4
+18.18%
13.19K
85.75K
May 11
Form 4
+25.29%
14.64K
72.56K
May 11
Form 4
+15.01%
7.56K
57.92K
May 12
Form 4
+19.16%
8.1K
50.36K
May 12
Form 4
+19.51%
6.9K
42.26K
May 15
Form 4
+20.71%
6.07K
35.36K
May 15
Form 4
+29.66%
6.7K
29.3K
May 17
Form 4
+129.33%
12.74K
22.59K
May 19
Form 4
+171.40%
6.22K
9.85K
Jan 8
Form 4
+23.98%
702
3.63K
Oct 31
Form 4
+417.09%
2.93K
3.63K
Jan 10
Form 4
0
0
Oct 31
Form 3
0
0
No matching records found

Menlo Therapeutics Inc. (VYNE) Snapshot price: $2.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
0
0
Jun 25
Form 3
0
0
No matching records found

X4 Pharmaceuticals, Inc (XFOR) Snapshot price: $0.8539

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+87.10%
45K
96.67K
Jun 10
Form 4
+674.97%
45K
51.67K
Jun 13
Form 4
6.67K
6.67K
Jun 6
Form 4
0
0
Jun 2
Form 4
0
0
Jun 10
Form 4
0
0
Jun 17
Form 4
0
0
Jun 5
Form 4/A
0
0
Nov 15
Form 4
0
0
Nov 15
Form 3
0
0
No matching records found